Click to edit Master title style
Breast Cancer Update Click to edit Master subtitle style
Wayne Jones
3/17/2015
FRACS
1
1
Topics
•Click Breast to Imaging edit Master title style Click to edit Master title style • Breast Surgery • Adjuvant Treatment Click to edit Master subtitle style
3/17/2015
2
2
2
Breast Imaging • Digital mammography Click to edit Master title • Tomosynthesis mammography Click to edit Master title • Office ultrasound • Image guided biopsies • MRI
style style
Click to edit Master subtitle style − High risk screening & specific questions − ? Lobular Ca & DCIS − Cost, claustrophobia, over-calls cancer
3/17/2015
3
3
3
Digital Mammography
Click to edit Master title style Click to edit Master title style Click to edit Master subtitle style
3/17/2015
4
4
4
Digital Mammography
Click to edit Master title style Click to edit Master title style Click to edit Master subtitle style
3/17/2015
5
5
5
Tomosynthesis Mammography
Click to edit Master title style
Click to edit Master subtitle style
3/17/2015
6
6
Office Ultrasound
Click to edit Master title style
Click to edit Master subtitle style
3/17/2015
7
7
U/S Guided Core Biopsy
Click to edit Master title style Click to edit Master title style Click to edit Master subtitle style
3/17/2015
8
8
8
Breast MRI
Click to edit Master title style Click to edit Master title style Click to edit Master subtitle style
3/17/2015
9
9
9
Click to edit Master title style
Breast Surgery Click to edit Master subtitle style
3/17/2015
10
10
Mastectomy
Click to edit Master title style
Click to edit Master subtitle style
3/17/2015
11
11
Breast Conservation Surgery
Click to edit Master title style
Click to edit Master subtitle style
3/17/2015
12
12
Breast Conservation Surgery
Click to edit Master title style
Click to edit Master subtitle style
3/17/2015
13
13
Sentinel Node Biopsy • 40% lymph node involvement Tumour Click to edit Master title style • U/S and FNA biopsy • Pre-op ID of sentinel node 95%+ • Smaller operation, less morbidity eg shoulder pain, lymphoedema Click to edit Master subtitle style • No difference in DFS or OS v AND Nodal Basin
3/17/2015
14
14
Lymphoscintogram
Click to edit Master title style
Click to edit Master subtitle style
3/17/2015
15
15
Patent Blue V Dye
Click to edit Master title style
Click to edit Master subtitle style
3/17/2015
16
16
Hand-held Gamma Probe
Click to edit Master title style Click to edit Master title style Click to edit Master subtitle style
3/17/2015
17
17
17
Hand-held Gamma Probe
Click to edit Master title style
Click to edit Master subtitle style
3/17/2015
18
18
Is Axillary Dissection Needed? • Currently if
Click to− SNBedit title style positiveMaster have ALND Click to− SNBedit title style negativeMaster avoid ALND • Isolated tumour cells <0.2mm – not significant • Micrometastases <2mm – increased LR, ? ALND
Click to edit Master subtitle style
• Micrometastases >2mm – Do ALND
• If 3 or more nodes involved omit ALND if getting systemic tx and DXR (Z-0011 trial, IBCSG 23-01) 3/17/2015
19
19
19
Breast Reconstruction • Offered to all ‘Mastectomy Patients’
Click to edit Master title style • Psycho-social & sexuality reasons Click to edit Master title style • Immediate or Delayed
• Implants – one or two stage
Click edit Master subtitle style • TRAM flapsto - muscle, fat & skin • DIEP flaps – fat & skin, microvascular
3/17/2015
20
20
20
Permanent Implants
Click to edit Master title style Click to edit Master title style Click to edit Master subtitle style
3/17/2015
21
21
21
How strong are they?
Click to edit Master title style
Click to edit Master subtitle style
3/17/2015
22
22
One Stage Implant
Click to edit Master title style Click to edit Master title style Click to edit Master subtitle style
3/17/2015
23
23
23
Two Stage Implant â&#x20AC;&#x201C; Pre-op
Click to edit Master title style Click to edit Master title style Click to edit Master subtitle style
3/17/2015
24
24
24
Two Stage Implants
Click to edit Master title style Click to edit Master title style Click to edit Master subtitle style
3/17/2015
25
25
25
Two Stage Implant - Expansion
Click to edit Master title style Click to edit Master title style Click to edit Master subtitle style
3/17/2015
26
26
26
Two Stage Implant â&#x20AC;&#x201C; Post-op
Click to edit Master title style Click to edit Master title style Click to edit Master subtitle style
3/17/2015
27
27
27
TRAM Flap
Click to edit Master title style Click to edit Master title style Click to edit Master subtitle style
3/17/2015
28
28
28
Delayed TRAM flap
Click to edit Master title style Click to edit Master title style Click to edit Master subtitle style
3/17/2015
29
29
29
Nipple Click to edit Master title style Reconstruction Click to edit Master subtitle style
3/17/2015
30
30
Nipple Reconstruction Click to edit Master title style
Click to edit Master subtitle style
3/17/2015
31
31
Nipple Sparing Mastectomy •Click No increased riskMaster breast cancer if preserve to edit title stylenipple − If >2cm fromMaster nipple, not multifocal Click to edit title style − Frozen Section at surgery
• Routine for prophylatic mastectomies • Selected cancer mastectomies
Click to edit Master subtitle style
− Not contra-indicated as above − Can preserve blood supply
• Inferolateral approach or peri-areola
3/17/2015
32
32
32
Nipple Sparing Mastectomy
Click to edit Master title style Click to edit Master title style Click to edit Master subtitle style
3/17/2015
33
33
33
Click to edit Master title style
Adjuvant Treatment Click to edit Master subtitle style
3/17/2015
34
34
Radiotherapy •Click All cases PartialMaster Mastectomy for DXR toofedit title style •Click Nodal status important to edit Master title style − Was >3 nodes, now 1 node treated (EBCTG 2014)
• Intra-operative DXR − Controversial − Some patients don’t need DXR at all − Editorial Int J Rad Onc 2015 91(2), p255-7
Click to edit Master subtitle style
• Partial breast irradiation
3/17/2015
35
35
35
Endocrine Therapy • Aromatase Inhibitors more effective than Tamoxifen
Click− to edit Master titlecancer style 17% less recurrence, 53% less contralateral
− Less DVT, Hot flushes, uterine Ca, more joint pain, lose bone density
• • • •
Can switch to AI after 2y Duration – 10y better than 5y to edit Master subtitle style PrimaryClick endocrine therapy if unfit for surgery Pre-menopausal women − Use Exemestane & Zoladex (GnRH inhibitor) − More effective than Tamoxifen (SOFT trial)
3/17/2015
36
36
Chemotherapy rd generation chemo •Click More effective 3 to edit Master title style • Use of multi-agents eg AC & Taxol, FEC & Taxol • Tailor treatment eg basal type, gene array analysis Click to Master • Neo-adjuvant tx edit for Her2 +ve subtitle & “triple style negative” • Management of Her2 +ve Ca <1cm controversial • Consider fertility treatment
3/17/2015
37
37
Herceptin (Trastuzumab) • 20% women HER2 +ve Click to edit Master title style • HERA Study – recurrence ↓46% • 12m course $80,000 • Give with chemo • 3m versus 12m? Click to edit Master subtitle style • Combination with Pertuzumab? • Need Portacath
3/17/2015
38
38
Click to edit Master title style
Click to edit Master subtitle style
3/17/2015
39
39
Click to edit Master title style Questions? Click to edit Master subtitle style
3/17/2015
40
40